| Dr Mark A Plunkett, MD OB/GYN | |
|
6600 Van Aalst Blvd, Fort Benning, GA 31905-2102 | |
| (762) 408-2605 | |
| Not Available |
| Full Name | Dr Mark A Plunkett |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 6600 Van Aalst Blvd, Fort Benning, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659323301 | NPI | - | NPPES |
| 200377920 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 70932 (Georgia) | Primary |
| Entity Name | Dhp Of Piedmont Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316202609 PECOS PAC ID: 9133378763 Enrollment ID: O20120925000798 |
News Archive
In late December 2015, the U.S. Food and Drug Administration proposed a number of new restrictions related to the use of tanning beds, including banning their use among individuals younger than 18 years.
The Association of Clinical Research Organizations, which represents the global CRO industry, today released the following statement regarding a report from the Office of the Inspector General (OIG) of the Department of Health and Human Services (HHS) titled Challenges to FDA's Ability to Monitor and Inspect Foreign Clinical Trials.
Sesen Bio, Inc., a late-stage clinical company developing fusion protein therapies for the treatment of cancer, today announced that the company will present its three-month Phase 3 VISTA Trial data during a poster session at the Global Congress on Bladder Cancer 2018.
It remains unclear whether a special ophthalmological examination of all children younger than 6 years (and potential follow-up treatments) would reduce the frequency and severity of visual impairment (amblyopia) in the population. An update search conducted for a benefit assessment of the German Institute for Quality and Efficiency in Health Care from 2008 identified no new screening study.
› Verified 5 days ago
| Entity Name | Dhp Of Piedmont Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316202609 PECOS PAC ID: 9133378763 Enrollment ID: O20201014001431 |
News Archive
In late December 2015, the U.S. Food and Drug Administration proposed a number of new restrictions related to the use of tanning beds, including banning their use among individuals younger than 18 years.
The Association of Clinical Research Organizations, which represents the global CRO industry, today released the following statement regarding a report from the Office of the Inspector General (OIG) of the Department of Health and Human Services (HHS) titled Challenges to FDA's Ability to Monitor and Inspect Foreign Clinical Trials.
Sesen Bio, Inc., a late-stage clinical company developing fusion protein therapies for the treatment of cancer, today announced that the company will present its three-month Phase 3 VISTA Trial data during a poster session at the Global Congress on Bladder Cancer 2018.
It remains unclear whether a special ophthalmological examination of all children younger than 6 years (and potential follow-up treatments) would reduce the frequency and severity of visual impairment (amblyopia) in the population. An update search conducted for a benefit assessment of the German Institute for Quality and Efficiency in Health Care from 2008 identified no new screening study.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark A Plunkett, MD OB/GYN Po Box 9186, Wvu Dept Of Obstetrics And Gynecology, Morgantown, WV 26506-9186 Ph: (304) 293-5631 | Dr Mark A Plunkett, MD OB/GYN 6600 Van Aalst Blvd, Fort Benning, GA 31905-2102 Ph: (762) 408-2605 |
News Archive
In late December 2015, the U.S. Food and Drug Administration proposed a number of new restrictions related to the use of tanning beds, including banning their use among individuals younger than 18 years.
The Association of Clinical Research Organizations, which represents the global CRO industry, today released the following statement regarding a report from the Office of the Inspector General (OIG) of the Department of Health and Human Services (HHS) titled Challenges to FDA's Ability to Monitor and Inspect Foreign Clinical Trials.
Sesen Bio, Inc., a late-stage clinical company developing fusion protein therapies for the treatment of cancer, today announced that the company will present its three-month Phase 3 VISTA Trial data during a poster session at the Global Congress on Bladder Cancer 2018.
It remains unclear whether a special ophthalmological examination of all children younger than 6 years (and potential follow-up treatments) would reduce the frequency and severity of visual impairment (amblyopia) in the population. An update search conducted for a benefit assessment of the German Institute for Quality and Efficiency in Health Care from 2008 identified no new screening study.
› Verified 5 days ago
Casey A Danielsen, D.O. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 6600 Van Aalst Blvd, Fort Benning, GA 31905 Phone: 762-408-2273 | |
Dr. Miles E Mahan, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6600 Van Aalst Blvd, Department Of Women's Health And Newborn Care, Fort Benning, GA 31905 Phone: 762-408-2605 | |
Michael Sean Dempsey, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7950 Martin Loop, Department Of Surgery, Ob/gyn Service, Fort Benning, GA 31905 Phone: 706-544-2319 Fax: 706-544-2736 |